Friday, September 9, 2016 | 12:00 PM - 4:00 PM
Speakers: Shohei Koide (NYU Langone Medical Center), Jonathan R. Lai (Albert Einstein College of Medicine), Jim Wells (University of California San Francisco), and Manoj Charati (Pfizer)
This symposium will highlight state-of-the-art technologies in protein and antibody engineering, and antibody-drug conjugates. The implementation of these methods to specific diseases, and unique research tools, will also be discussed.
September 21 - 23, 2016
Featuring: Peder Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)
Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.
Monday, June 13, 2016 | 10:00 AM - 3:30 PM
Speakers: Ruslan M. Medzhitov (Yale School of Medicine, Howard Hughes Medical Institute), Mauro Perretti (The William Harvey Research Institute, Queen Mary University of London), Charles N. Serhan (Brigham and Women's Hospital & Harvard Medical School), Lars Klareskog (Karolinska Institutet), and Kevin J. Tracey (The Feinstein Institute for Medical Research)
This symposium will honor Dr. Charles N. Serhan, the recipient of the 2016 Ross Prize in Molecular Medicine, for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases.
Tuesday, April 26, 2016 | 9:00 AM - 5:00 PM
Speakers: Dax Fu (Johns Hopkins School of Medicine), Kathleen M. Giacomini (University of California, San Francisco), Matthias A. Hediger (University of Bern), Avner Schlessinger (Icahn School of Medicine at Mount Sinai), Giulio Superti-Furga (Austrian Academy of Sciences), Ming Zhou (Baylor College of Medicine), and Kim Huard (Pfizer Inc.)
Solute Carrier Proteins are an untapped resource for drug discovery. This event will discuss breakthroughs in structural biology, cell engineering and metabolomics that hold the promise of "unlocking" this gene family.
Thursday, January 21, 2016 | 8:30 AM - 5:30 PM
Speakers: David Eliezer (Weill Cornell Medical College), Andras Fiser (Albert Einstein College of Medicine), Ruben Gonzalez (Columbia University), Balasubramanian Harish (Princeton University), Ron Koder (City College of New York), Filippo Mancia (Columbia University), Smita Patel (Rutgers University), Stefano Piana-Agostinetti (D.E. Shaw Research), Betsy Speltz (Yale University), Corey Wilson (Yale University)
The New York Area Structural Biology Discussion Group convenes twice annually and presents talks and poster sessions from graduate students, postdocs, and laboratory heads.
Tuesday, December 8, 2015 | 8:30 AM - 4:45 PM
Speakers: David D'Alessio (Duke University), Richard DiMarchi (Indiana University), Jean-Philippe Fortin (Pfizer Global), Keld Fosgerau (Zealand Pharma A/S), Matthew R. Hayes (Perelman School of Medicine, University of Pennsylvania), George G. Holz (State University of New York), Beat Jucker (GlaxoSmithKline), Dong Seok Kim (National Institute on Aging / Peptron Inc), Lotte Bjerre Knudsen (Novo Nordisk), Patrick M. Sexton (Monash University), Konrad Talbot (Cedars-Sinai Medical Center)
GLP-1 receptor agonists have improved treatment options in type 2 diabetes, although realizing their promise in other areas remains challenging. This symposium highlights preclinical and clinical breakthroughs and opportunities for drug development.
Edited by Markus Lambertz
and Steven F. Perry
(University of Bonn, Bonn, Germany)
Papers in this special issue of Annals discuss interdisciplinary topics in respiratory science
Organizers: Robert Martone (St. Jude Children's Research Hospital) and Sonya Dougal (The New York Academy of Sciences)
This eBriefing explores tau-related mechanisms of neurodegeneration and emerging therapeutic strategies focused on tau.
Organizers: Michael Foley (Tri-Institutional Therapeutics Discovery Institute), Ralph Garippa (Memorial Sloan-Kettering Cancer Center), David Mark (F. Hoffmann-La Roche), Lorenz Mayr (Astra Zeneca), John Moffat (Genentech), Marco Prunotto (F. Hoffmann-La Roche), and Sonya Dougal (The New York Academy of Sciences)
This eBriefing considers the merits of phenotypic drug discovery, which is experiencing a renaissance of interest. The method aims to find therapeutically useful compounds by screening thousands of substances for functional cellular outputs.
Featured Speaker: Bert Vogelstein (Johns Hopkins School of Medicine; Howard Hughes Medical Institute)
This eBriefing features the work of Bert Vogelstein, recipient of the 2015 Dr. Paul Janssen Award for Biomedical Research, and covers topics at the forefront of precision medicine.